Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 746935, 8 pages
http://dx.doi.org/10.1155/2008/746935
Research Article

Regulation of Peroxisome Proliferator-Activated Receptors by E6-Associated Protein

1The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA
2Center for Molecular Toxicology and Carcinogenesis, Department of Veterinary & Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA

Received 29 May 2008; Revised 25 September 2008; Accepted 5 November 2008

Academic Editor: Wei Xu

Copyright © 2008 Lakshmi Gopinathan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. N. Feige, L. Gelman, L. Michalik, B. Desvergne, and W. Wahli, “From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions,” Progress in Lipid Research, vol. 45, no. 2, pp. 120–159, 2006. View at Publisher · View at Google Scholar
  2. B. Desvergne, L. Michalik, and W. Wahli, “Be fit or be sick: peroxisome proliferator-activated receptors are down the road,” Molecular Endocrinology, vol. 18, no. 6, pp. 1321–1332, 2004. View at Publisher · View at Google Scholar
  3. P. Escher and W. Wahli, “Peroxisome proliferator-activated receptors: insight into multiple cellular functions,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 448, no. 2, pp. 121–138, 2000. View at Publisher · View at Google Scholar
  4. S. Yu and J. K. Reddy, “Transcription coactivators for peroxisome proliferator-activated receptors,” Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 936–951, 2007. View at Publisher · View at Google Scholar
  5. C. K. Glass and M. G. Rosenfeld, “The coregulator exchange in transcriptional functions of nuclear receptors,” Genes & Development, vol. 14, no. 2, pp. 121–141, 2000. View at Google Scholar
  6. A. Ismail and Z. Nawaz, “Nuclear hormone receptor degradation and gene transcription: an update,” IUBMB Life, vol. 57, no. 7, pp. 483–490, 2005. View at Publisher · View at Google Scholar
  7. H. K. Kinyamu, J. Chen, and T. K. Archer, “Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors,” Journal of Molecular Endocrinology, vol. 34, no. 2, pp. 281–297, 2005. View at Publisher · View at Google Scholar
  8. C. Rochette-Egly, “Dynamic combinatorial networks in nuclear receptor-mediated transcription,” The Journal of Biological Chemistry, vol. 280, no. 38, pp. 32565–32568, 2005. View at Publisher · View at Google Scholar
  9. T. Matsuura, J. S. Sutcliffe, P. Fang et al., “De novo truncating mutations in E6-Ap ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome,” Nature Genetics, vol. 15, no. 1, pp. 74–77, 1997. View at Publisher · View at Google Scholar
  10. C. L. Smith, D. G. DeVera, D. J. Lamb et al., “Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction,” Molecular and Cellular Biology, vol. 22, no. 2, pp. 525–535, 2002. View at Publisher · View at Google Scholar
  11. Z. Nawaz, D. M. Lonard, C. L. Smith et al., “The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily,” Molecular and Cellular Biology, vol. 19, no. 2, pp. 1182–1189, 1999. View at Google Scholar
  12. A. Mani, A. S. Oh, E. T. Bowden et al., “E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells,” Cancer Research, vol. 66, no. 17, pp. 8680–8686, 2006. View at Publisher · View at Google Scholar
  13. T. Munakata, Y. Liang, S. Kim et al., “Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein,” PLoS Pathogens, vol. 3, no. 9, pp. 1335–1347, 2007. View at Publisher · View at Google Scholar
  14. M. Scheffner, J. M. Huibregtse, R. D. Vierstra, and P. M. Howley, “The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53,” Cell, vol. 75, no. 3, pp. 495–505, 1993. View at Publisher · View at Google Scholar
  15. Y. Liu and J. D. Baleja, “Structure and function of the papillomavirus E6 protein and its interacting proteins,” Frontiers in Bioscience, vol. 13, no. 1, pp. 121–134, 2008. View at Publisher · View at Google Scholar
  16. E. S. Tien, J. W. Davis, and J. P. Vanden Heuvel, “Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor α coregulator,” The Journal of Biological Chemistry, vol. 279, no. 23, pp. 24053–24063, 2004. View at Publisher · View at Google Scholar
  17. J. P. Gray, J. W. Davis II, L. Gopinathan, T. L. Leas, C. A. Nugent, and J. P. Vanden Heuvel, “The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-α,” Toxicological Sciences, vol. 89, no. 2, pp. 535–546, 2006. View at Publisher · View at Google Scholar
  18. S. S.-T. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995. View at Google Scholar
  19. E. S. Tien, J. P. Gray, J. M. Peters, and J. P. Vanden Heuvel, “Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor α-dependent growth regulatory genes,” Cancer Research, vol. 63, no. 18, pp. 5767–5780, 2003. View at Google Scholar
  20. H. K. Kinyamu and T. K. Archer, “Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in Mdm2 protein expression,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5867–5881, 2003. View at Publisher · View at Google Scholar
  21. A. M. Burger, Y. Gao, Y. Amemiya et al., “A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer,” Cancer Research, vol. 65, no. 22, pp. 10401–10412, 2005. View at Publisher · View at Google Scholar
  22. J. Zhang, M. G. Guenther, R. W. Carthew, and M. A. Lazar, “Proteasomal regulation of nuclear receptor corepressor-mediated repression,” Genes & Development, vol. 12, no. 12, pp. 1775–1780, 1998. View at Publisher · View at Google Scholar
  23. C. Blanquart, O. Barbier, J.-C. Fruchart, B. Staels, and C. Glineur, “Peroxisome proliferator-activated receptor α (PPARα) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes,” The Journal of Biological Chemistry, vol. 277, no. 40, pp. 37254–37259, 2002. View at Publisher · View at Google Scholar
  24. C. Blanquart, R. Mansouri, J.-C. Fruchart, B. Staels, and C. Glineur, “Different ways to regulate the PPARα stability,” Biochemical and Biophysical Research Communications, vol. 319, no. 2, pp. 663–670, 2004. View at Publisher · View at Google Scholar
  25. D. Genini and C. V. Catapano, “Block of nuclear receptor ubiquitination: a mechanism of ligand-dependent control of peroxisome proliferator-activated receptor δ activity,” The Journal of Biological Chemistry, vol. 282, no. 16, pp. 11776–11785, 2007. View at Publisher · View at Google Scholar
  26. M. Rieck, L. Wedeken, S. Müller-Brüsselbach, W. Meissner, and R. Müller, “Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor β,” FEBS Journal, vol. 274, no. 19, pp. 5068–5076, 2007. View at Publisher · View at Google Scholar
  27. S. Hauser, G. Adelmant, P. Sarraf, H. M. Wright, E. Mueller, and B. M. Spiegelman, “Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation,” The Journal of Biological Chemistry, vol. 275, no. 24, pp. 18527–18533, 2000. View at Publisher · View at Google Scholar
  28. R. C. Conaway, C. S. Brower, and J. W. Conaway, “Emerging roles of ubiquitin in transcription regulation,” Science, vol. 296, no. 5571, pp. 1254–1258, 2002. View at Publisher · View at Google Scholar
  29. G. Reid, M. R. Hübner, R. Métivier et al., “Cyclic, proteasome-mediated turnover of unliganded and liganded ERa on responsive promoters is an integral feature of estrogen signaling,” Molecular Cell, vol. 11, no. 3, pp. 695–707, 2003. View at Publisher · View at Google Scholar
  30. J.-S. Qi, Y. Yuan, V. Desai-Yajnik, and H. H. Samuels, “Regulation of the mdm2 oncogene by thyroid hormone receptor,” Molecular and Cellular Biology, vol. 19, no. 1, pp. 864–872, 1999. View at Google Scholar
  31. B.-X. Zhao, H.-Z. Chen, N.-Z. Lei et al., “p53 mediates the negative regulation of MDM2 by orphan receptor TR3,” The EMBO Journal, vol. 25, no. 24, pp. 5703–5715, 2006. View at Publisher · View at Google Scholar
  32. W. Huang, J. Zhang, M. Washington et al., “Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor,” Molecular Endocrinology, vol. 19, no. 6, pp. 1646–1653, 2005. View at Publisher · View at Google Scholar
  33. M. Shirakura, K. Murakami, T. Ichimura et al., “E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein,” Journal of Virology, vol. 81, no. 3, pp. 1174–1185, 2007. View at Publisher · View at Google Scholar
  34. S. Dharancy, M. Malapel, G. Perlemuter et al., “Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection,” Gastroenterology, vol. 128, no. 2, pp. 334–342, 2005. View at Publisher · View at Google Scholar
  35. Y. Cheng, S. Dharancy, M. Malapel, and P. Desreumaux, “Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor α and carnitine palmitoyl acyl-CoA transferase 1A,” World Journal of Gastroenterology, vol. 11, no. 48, pp. 7591–7596, 2005. View at Google Scholar
  36. A. De Gottardi, V. Pazienza, P. Pugnale et al., “Peroxisome proliferator-activated receptor-a and -? mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection,” Alimentary Pharmacology & Therapeutics, vol. 23, no. 1, pp. 107–114, 2006. View at Publisher · View at Google Scholar
  37. B. Rakic, S. M. Sagan, M. Noestheden et al., “Peroxisome proliferator-activated receptor a antagonism inhibits hepatitis C virus replication,” Chemistry & Biology, vol. 13, no. 1, pp. 23–30, 2006. View at Publisher · View at Google Scholar